Dynasil Corporation of America Reports Fiscal Year 2011 Financial Results
- Revenue Increases 9 Percent to $47 Million
- Company Posts Net Income of $1.4 Million, EPS of $0.08
WATERTOWN, Mass — 12/29/2011 (CRWENEWSWIRE) — Dynasil Corporation of America (NASDAQ:DYSL), a leading developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today reported financial results for fiscal year ended September 30, 2011.
Revenue for fiscal 2011 increased to $47.0 million compared with $43.0 million in fiscal 2010. Contract Research segment revenue increased to $24.9 million from $23.1 million in fiscal 2010. The Company’s renamed Products & Technology segment (previously called “Optics/Photonics, Products & Instruments”) posted revenue of $22.1 million, up from $19.9 million a year earlier.
Net income for the 12 months ended September 30, 2011 was $1.4 million, or $0.08 per diluted share, compared with $3.2 million, or $0.22 per diluted share, in fiscal 2010. Lower net income in the 2011 period resulted from higher selling, general and administrative expenses and increased investment in corporate growth initiatives, partially offset by Research & Experimentation (R&E) Tax Credits. For fiscal year 2011, the Company had an income tax expense of $293,198 compared with an income tax expense of $929,661 for fiscal year 2010. The significant difference primarily resulted from state and federal R&E tax credits of approximately $1.5 million in fiscal 2011, partially offset by the required deferred tax liability recorded for the tax effects of book/tax differences related to Property, Plant and Equipment, Goodwill, and Intangible Assets.
“Dynasil delivered 9 percent revenue growth in 2011, with gains in both business segments despite a challenging economic environment,” said Steven Ruggieri, the Company’s president and chief executive officer. “Our Contract Research segment grew $1.8 million, or nearly 8 percent, from fiscal 2010, reflecting robust business with key federal customers including the U.S. Department of Homeland Security and the U.S. Department of Energy. Our Products & Technology segment grew more than $2 million, or 11 percent, from the year-earlier period, primarily as a result of our acquisition of Hilger Crystals in the fourth quarter of fiscal 2010.”
Product Pipeline
“During the fourth quarter of 2011 we began shipping our dual-mode radiation detectors to OEM customers for beta testing, and we remain on track to begin generating revenue from this program in 2012,” Ruggieri said. “Our dual-mode technology represents the first in a planned pipeline of scintillation crystal products capable of advanced radiation detection for markets including homeland security, baggage screening and energy.”
“Our product pipeline also includes sensors for non destructive testing, radiation dosimeters based on technologies developed at our RMD Research business unit and thin film digital X-rays,” Ruggieri continued. “In addition, we are testing and evaluating three of the biomedical technologies acquired earlier this year from Dr. Daniel Ericson. While development is still in the early stages, we believe that these technologies have commercial potential.”
Recent Highlights
* Dynasil promoted Kanai S. Shah, Ph.D., Vice President of Research and leader of the Materials Science Group, to President of RMD Research, the Company’s research business unit, beginning in December. Dr. Shah, 50, joined RMD in 1985 as a Staff Scientist. He became Director of Research in 2002 and Vice President of Research in 2009. He has been responsible for new semiconductor and scintillator development at RMD for more than a decade.
* RMD Research received contracts totaling $3.65 million from the Department of Homeland Security’s Domestic Nuclear Detection Office (DNDO). These contracts provide funded research and development of gamma and neutron radiation detectors capable of identifying illicit nuclear materials. The contracts consist of $2.15 million under the DNDO’s Exploratory Research Program (ERP) and $1.5 million under the Small Business Innovation Research (SBIR) program. Earlier this month, the U.S. House and Senate negotiated a deal to reauthorize the SBIR program for an additional six years.
“In fiscal 2011 we made good progress in expanding our product pipeline and diversifying our contract research business,” Ruggieri said. “In the coming quarters, we expect to have a product realization process in place designed to support the evaluation, assessment, development and commercialization of our technologies. We have a number of exciting milestones to look forward to in 2012, and we believe that we are well positioned for continued growth.”
Conference Call Information
As previously announced, Dynasil Corporation will host a conference call for investors and analysts Thursday, December 29, 2011 at 5:00 p.m. ET. On the call will be Dynasil President and Chief Executive Officer Steven Ruggieri and Chief Financial Officer Richard Johnson. Those who wish to listen to the conference call and view presentation slides should visit the Investor Information section of the Company’s website at www.dynasilcorp.com. The call also may be accessed by dialing (877) 407-5790 or (201) 689-8328. For interested individuals unable to join the live conference call, a webcast replay will be available on the Company’s website for one year.
About Dynasil
Dynasil Corporation of America develops and manufactures detection, sensing and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets. Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the Company is available at www.dynasilcorp.com.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management, including, without limitation, our expectations regarding results of operations, the commercialization of our products including our dual mode detectors, our development of new technologies including at Dynasil Biomedical, the adequacy of our current financing sources, our capital expenditures and the strength of our intellectual property portfolio. These forward-looking statements may be identified by the use of words such as “may,” “could,” “expect,” “estimate,” anticipate,” continue” or similar terms, though not all forward-looking statements contain such words. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, our ability to develop and commercialize our products, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management personnel, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company’s Annual Report on Form 10-K and from time to time in the Company’s other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Source: Dynasil Corporation of America
Contact:
Dynasil Corporation of America
Patty Kehe, 617-668-6855
pkehe@dynasilcorp.com
or
Sharon Merrill
David Calusdian, 617-542-5300
Executive Vice President and Partner
DYSL@InvestorRelations.com
| DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES | |||||
| CONSOLIDATED BALANCE SHEET | |||||
| ASSETS | |||||
| 2011 | 2010 | ||||
| Current assets | |||||
| Cash and cash equivalents | $ | 4,479,840 | $ | 4,111,966 | |
|
Accounts receivable, net of allowance for doubtful accounts of $182,634 and $132,584 and sales returns allowance of $18,356 and $24,168 for September 30, 2011 and September 30, 2010, respectively.
|
5,837,139 | 6,360,583 | |||
| Inventories | 3,250,539 | 3,097,219 | |||
| Costs in excess of billings | 408,240 | 135,157 | |||
| Deferred tax asset | 1,119,800 | 1,196,735 | |||
| Prepaid income taxes | 341,825 | 166,231 | |||
| Prepaid expenses and other current assets | 453,738 | 453,418 | |||
| Total current assets | 15,891,121 | 15,521,309 | |||
| Property, Plant and Equipment, net | 4,860,328 | 3,953,319 | |||
| Other Assets | |||||
| Intangibles, net | 6,374,329 | 6,671,149 | |||
| Goodwill | 13,330,182 | 13,775,087 | |||
| Deferred tax asset - non current | 694,800 | -0- | |||
| Deferred financing costs, net | 150,656 | 190,568 | |||
| Total other assets | 20,549,967 | 20,636,804 | |||
| Total Assets | $ | 41,301,416 | $ | 40,111,432 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||
| Current Liabilities | |||||
| Current portion of long-term debt | $ | 1,859,728 | $ | 1,870,779 | |
| Accounts payable | 2,088,395 | 1,482,250 | |||
| Accrued expenses and other liabilities | 2,322,459 | 2,177,743 | |||
| Contingent consideration | 183,713 | -0- | |||
| Dividends payable |
-0-
|
131,400 | |||
| Total current liabilities | 6,454,295 | 5,662,172 | |||
| Long-term Liabilities | |||||
| Long-term debt, net | 8,985,442 | 10,833,334 | |||
| Deferred tax liability | 1,619,637 | 873,300 | |||
| Contingent consideration | -0- | 750,000 | |||
| Total long-term liabilities | 10,605,079 | 12,456,634 | |||
| Temporary Equity | 2,000,000 | 2,000,000 | |||
| Stockholders’ Equity | 22,242,042 | 19,992,626 | |||
| Total Liabilities and Stockholders’ Equity | $ | 41,301,416 | $ | 40,111,432 | |
| DYNASIL CORPORATION OF AMERICA | ||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||
| 2011 | 2010 | |||||
| Net revenue | $ | 46,951,666 | $ | 42,969,762 | ||
| Cost of revenue | 27,683,729 | 25,205,960 | ||||
| Gross profit | 19,267,937 | 17,763,802 | ||||
| Selling, general and administrative expenses | 17,021,191 | 12,971,640 | ||||
| Income from operations | 2,246,746 | 4,792,162 | ||||
| Interest expense, net | 601,903 | 628,120 | ||||
| Income before income taxes | 1,644,843 | 4,164,042 | ||||
| Income taxes | 293,198 | 929,661 | ||||
| Net income | $ | 1,351,645 | $ | 3,234,381 | ||
| Net Income | $ | 1,351,645 | $ | 3,234,381 | ||
| Other comprehensive income: | ||||||
|
Foreign currency translation, net of $83,318 and $77,400 income taxes in 2011 and 2010
|
147,404 | 150,162 | ||||
| Total comprehensive income | $ | 1,499,049 | $ | 3,384,543 | ||
| Net income | $ | 1,351,645 | $ | 3,234,381 | ||
| Dividends on preferred stock | 116,646 | 537,433 | ||||
| Net income applicable to common stockholders | 1,234,999 | 2,696,948 | ||||
| Dividend add back due to preferred stock conversion | -0- | 537,433 | ||||
| Net income for diluted income per common share | $ | 1,234,999 | $ | 3,234,381 | ||
| Basic net income per common share | $ | 0.08 | $ | 0.22 | ||
| Diluted net income per common share | $ | 0.08 | $ | 0.22 | ||
| Weighted average shares outstanding | ||||||
| Basic | 14,932,226 | 12,404,701 | ||||
| Diluted | 15,127,004 | 14,937,575 | ||||
********************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
